1. Home
  2. ZVRA vs PFL Comparison

ZVRA vs PFL Comparison

Compare ZVRA & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • PFL
  • Stock Information
  • Founded
  • ZVRA 2006
  • PFL 2003
  • Country
  • ZVRA United States
  • PFL United States
  • Employees
  • ZVRA N/A
  • PFL N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • PFL Finance Companies
  • Sector
  • ZVRA Health Care
  • PFL Finance
  • Exchange
  • ZVRA Nasdaq
  • PFL Nasdaq
  • Market Cap
  • ZVRA 467.6M
  • PFL 374.5M
  • IPO Year
  • ZVRA 2015
  • PFL N/A
  • Fundamental
  • Price
  • ZVRA $10.54
  • PFL $8.62
  • Analyst Decision
  • ZVRA Strong Buy
  • PFL
  • Analyst Count
  • ZVRA 8
  • PFL 0
  • Target Price
  • ZVRA $22.57
  • PFL N/A
  • AVG Volume (30 Days)
  • ZVRA 2.6M
  • PFL 113.7K
  • Earning Date
  • ZVRA 11-11-2025
  • PFL 01-01-0001
  • Dividend Yield
  • ZVRA N/A
  • PFL 11.53%
  • EPS Growth
  • ZVRA N/A
  • PFL N/A
  • EPS
  • ZVRA N/A
  • PFL N/A
  • Revenue
  • ZVRA $62,020,000.00
  • PFL N/A
  • Revenue This Year
  • ZVRA $336.43
  • PFL N/A
  • Revenue Next Year
  • ZVRA $54.26
  • PFL N/A
  • P/E Ratio
  • ZVRA N/A
  • PFL N/A
  • Revenue Growth
  • ZVRA 161.81
  • PFL N/A
  • 52 Week Low
  • ZVRA $6.19
  • PFL $6.98
  • 52 Week High
  • ZVRA $13.16
  • PFL $8.62
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 58.13
  • PFL 64.50
  • Support Level
  • ZVRA $9.08
  • PFL $8.41
  • Resistance Level
  • ZVRA $11.08
  • PFL $8.70
  • Average True Range (ATR)
  • ZVRA 0.62
  • PFL 0.06
  • MACD
  • ZVRA 0.24
  • PFL 0.01
  • Stochastic Oscillator
  • ZVRA 72.23
  • PFL 72.86

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest

PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.

Share on Social Networks: